The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial
NCT ID: NCT07027891
Last Updated: 2025-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
4670 participants
INTERVENTIONAL
2025-07-01
2028-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The patients in control group would be managed with usual care using HEART score in addition to recent acute coronary syndrome guideline.
No interventions assigned to this group
AI-ECG group
The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.
AI-ECG
The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AI-ECG
The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* suspicious of acute myocardial infarction
Exclusion Criteria
* Revisit of same symptoms within 1 week
* traumatic chest pain
* Pneumothorax
* Transferred from other hospital diagnosed of AMI
* Cardiac arrest
* Chest pain of clearly non-cardiac etiology
* declined to participate in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHA University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kyuseok Kim
Professor, MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
KYUSEOK Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHA University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asan Medical Center
Seoul, , South Korea
CHA Bundang Medical Center
Seoul, , South Korea
Ewha Womans University
Seoul, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Hanyang University
Seoul, , South Korea
Jeonbuk National University Hospital
Seoul, , South Korea
Korea University Ansan Hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Kyung Hee University Hospital
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Soonchunhyang University Bucheon Hospital
Seoul, , South Korea
Yonsei University Wonju College of Medicine
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Won Young Kim
Role: primary
Kyuseok Kim
Role: primary
Chul Han
Role: primary
Sung Phil Chung
Role: primary
Tae Ho Im
Role: primary
Jae Chol Yoon
Role: primary
Sejoong Ahn
Role: primary
Sung Hyuk Choi
Role: primary
Ki Young Jeong
Role: primary
Tae Gun Shin
Role: primary
Hyun Noh
Role: primary
Kyung Chul Cha
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RS-2025-02213791
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
ROMIAE II trial
Identifier Type: -
Identifier Source: org_study_id